UMediC Group Berhad
UMediC Group Berhad, an investment holding company, develops, manufactures, markets, and distributes medical devices and consumables in Malaysia, the Asia Pacific, the Americas, Europe, the Middle East, Africa, and Oceania. The company operates nursing homes and healthcare centers, and other related services; markets and distributes laboratory equipment and consumables; and provides after-sales s… Read more
Market Cap & Net Worth: UMediC Group Berhad (0256)
UMediC Group Berhad (KLSE:0256) has a market capitalization of $26.57 Million (RM119.65 Million) as of March 19, 2026. Listed on the KLSE stock exchange, this Malaysia-based company holds position #29946 globally and #609 in its home market, demonstrating a 6.67% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying UMediC Group Berhad's stock price RM0.32 by its total outstanding shares 373910000 (373.91 Million).
UMediC Group Berhad Market Cap History: 2022 to 2026
UMediC Group Berhad's market capitalization history from 2022 to 2026. Data shows change from $56.45 Million to $26.57 Million (-8.36% CAGR).
UMediC Group Berhad Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how UMediC Group Berhad's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.57x
UMediC Group Berhad's market cap is 0.57 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
3.42x
UMediC Group Berhad's market cap is 3.42 times its annual earnings
1.94x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $56.45 Million | $50.74 Million | $6.43 Million | 1.11x | 8.78x |
| 2023 | $58.53 Million | $45.43 Million | $10.32 Million | 1.29x | 5.67x |
| 2024 | $51.89 Million | $54.57 Million | $8.99 Million | 0.95x | 5.77x |
| 2025 | $27.81 Million | $48.56 Million | $8.13 Million | 0.57x | 3.42x |
Competitor Companies of 0256 by Market Capitalization
Companies near UMediC Group Berhad in the global market cap rankings as of March 19, 2026.
Key companies related to UMediC Group Berhad by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
UMediC Group Berhad Historical Marketcap From 2022 to 2026
Between 2022 and today, UMediC Group Berhad's market cap moved from $56.45 Million to $ 26.57 Million, with a yearly change of -8.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | RM26.57 Million | -4.48% |
| 2025 | RM27.81 Million | -46.40% |
| 2024 | RM51.89 Million | -11.35% |
| 2023 | RM58.53 Million | +3.68% |
| 2022 | RM56.45 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of UMediC Group Berhad was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $26.57 Million USD |
| MoneyControl | $26.57 Million USD |
| MarketWatch | $26.57 Million USD |
| marketcap.company | $26.57 Million USD |
| Reuters | $26.57 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.